Plosker, Greg L.; Hurst, Miriam - In: PharmacoEconomics 19 (2001) 11, pp. 1111-1134
practice are regimens such as cisplatin or carboplatin combined with paclitaxel, vinorelbine, gemcitabine, docetaxel or … analyses have been conducted on paclitaxel in NSCLC and most have focused on its use in combination with cisplatin. In terms of … clinical efficacy, paclitaxel-cisplatin combinations achieved significantly higher response rates than teniposide plus …